To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes.
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill, H.R. 5393 from the 118th Congress, proposes amendments to Title XVIII of the Social Security Act to ensure a fair assessment of pharmacy performance and quality under Medicare Part D. The bill aims to modify how pharmacies are evaluated within the Medicare Part D program, which provides prescription drug coverage to Medicare beneficiaries. The goal is to establish equitable criteria or methods for assessing pharmacy quality and performance, potentially impacting pharmacies participating in Medicare Part D and the administration of the program.
H.R. 5393 seeks to amend Medicare Part D pharmacy performance assessments to promote fairness, but it did not advance beyond referral to a subcommittee and has since expired.
- The bill targets amendments to Title XVIII of the Social Security Act, specifically related to Medicare Part D.
- It focuses on ensuring fair assessment methods for pharmacy performance and quality under Medicare Part D.
- The bill was referred to the House Subcommittee on Health but did not progress further and is currently failed or expired.
['Pharmacies participating in Medicare Part D', 'Medicare beneficiaries receiving prescription drug coverage', 'Centers for Medicare & Medicaid Services (CMS) as the program administrator']
['The bill text is not available, limiting detailed analysis of implementation mechanisms or cost implications.', "Potential challenges in defining and operationalizing 'fair assessment' criteria for pharmacy performance.", 'Oversight and enforcement provisions are unknown due to lack of full bill text, which may affect accountability.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on December 17, 2024. It did not advance beyond this stage and is now classified as failed or expired. The policy area is health, specifically focusing on Medicare Part D pharmacy quality measures, a subject of ongoing legislative and regulatory interest.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential changes in pharmacy behavior or service quality due to revised assessment criteria under Medicare Part D.', 'Possible administrative adjustments within CMS to accommodate new assessment standards.', "Impact on Medicare beneficiaries' access to pharmacies if assessment changes affect pharmacy participation."]
The absence of the full bill text and official summary limits transparency and comprehensive analysis. Tracking the bill's referral and failure status provides insight into legislative progress. Future proposals on this topic should ensure availability of complete documentation to facilitate public and stakeholder review.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.